-
Mashup Score: 6FDA Roundup: July 26, 2024 - 4 hour(s) ago
FDA Roundup: July 26, 2024
Source: www.fda.govCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
The U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) Patient-Focused Drug Development (PFDD) program welcomes you to the Clinical Outcome Assessment in Cancer Clinical Trials (COA-CCT) 9th annual workshop.
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6Pediatric Oncology Drug Approvals - 9 hour(s) ago
Pediatric Oncology Drug Approvals
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2FDA | NIH : Regulatory Do’s and Don’ts: Tips from FDA - 1 day(s) ago
FDA | NIH : Regulatory Do’s and Don’ts: Tips from FDA
Source: www.fda.govCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 2National Hispanic Family Cancer Awareness - 1 day(s) ago
An Oncology Center of Excellence Project Community Initiative #LatinePuede!
Source: www.fda.govCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 3July 25, 2024 Meeting of the Oncologic Drugs AC - 1 day(s) ago
July 25, 2024 Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement
Source: www.fda.govCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0
East Windsor, New Jersey. Aurobindo Pharma USA, Inc., on behalf of AuroHealth, is voluntarily recalling one lot (refer table below) of Healthy Living Migraine Relief, Acetaminophen 250mg, Aspirin (NSAID) 250mg & Caffeine 65mg tablets, to the consumer level as sold through Amazon to known within th
Source: www.fda.govCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 13FDA Roundup: July 23, 2024 - 2 day(s) ago
FDA Roundup: July 23, 2024
Source: www.fda.govCategories: General Medicine News, General HCPsTweet-
Check out the latest FDA Roundup, our at-a-glance summary of agency updates: https://t.co/pviBGAylS3 On Monday, the FDA approved the first orally disintegrating tablet approved for the prevention of pregnancy. https://t.co/x7CarexeKe On Monday, the FDA published common… https://t.co/1eaMfYX0io https://t.co/erOxvrO9MY
-
-
Mashup Score: 7July 25, 2024 Meeting of the Oncologic Drugs AC - 2 day(s) ago
July 25, 2024 Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement
Source: www.fda.govCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 4
Main Products, Inc. is voluntarily recalling all lots of “Umary Acido Hialuronico, Suplemento Alimenticio – 30 Capletas de 850mg” to the consumer level. FDA laboratory analysis confirmed that UMARY has been found to be tainted with the drug ingredients, diclofenac and omeprazole. Products containing
Source: www.fda.govCategories: General Medicine News, General HCPsTweet
Check out the latest FDA Roundup, our at-a-glance summary of agency updates: https://t.co/ZUcyZH6wGr Today, we approved Palforzia to include initiation of treatment, up-dosing and maintenance in individuals ages 1 through 3 years with a confirmed diagnosis of peanut allergy to… https://t.co/s1aCO5ltrl https://t.co/NPzLqBNXKd